Innovative Cancer Therapy

Month: March 2025

Sintilimab in Combination with Stereotactic Body Radiotherapy and Granulocyte-Macrophage Colony-Stimulating Factor for Metastatic Non-Small Cell Lung Cancer: The Multicenter SWORD Phase 2 Trial 朱正飞

朱正飞

Sintilimab in Combination with Stereotactic Body Radiotherapy and Granulocyte-Macrophage Colony-Stimulating Factor for Metastatic Non-Small Cell Lung Cancer: The Multicenter SWORD Phase 2 Trial

prag.app 2025年3月31日

Authors: Zhu Zhengfei et al. Fudan University Shanghai Cancer Center Translated by: Kong Yuehong Reviewed by: Zhang...

Latest Research from the Department of Head and Neck Radiotherapy at Zhejiang Cancer Hospital: Chen Xiaozhong and Cao Canneng Team | New Voice in Radioimmunotherapy for Glioblastoma

Latest Research from the Department of Head and Neck Radiotherapy at Zhejiang Cancer Hospital: Chen Xiaozhong and Cao Canneng Team | New Voice in Radioimmunotherapy for Glioblastoma

prag.app 2025年3月30日

Source of Research Article: Cao C, Wang L, Jiang F, et al. Granulocyte-macrophage colony-stimulating factor for newly...